375
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose

, PharmD, , PharmD, , PharmD, , PharmD, , PharmD & , PhDORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Terence M. Hughes, Alexander Kalicki, Zina Huxley-Reicher, Wilma Toribio, Don L. Samuels, Jeffrey J. Weiss, Michael Herscher & Linda Wang. (2022) A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic. Substance Abuse 43:1, pages 988-992.
Read now

Articles from other publishers (6)

Samuel O. Adeosun. (2022) Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?. Journal of Pharmacy Practice 36:4, pages 941-952.
Crossref
Heidi N. Eukel, Jayme Steig, Alyssa Hodges, Brianna O'Gary & Mark A. Strand. (2023) Nurse delivered medication safety screening program for home care visits. Public Health Nursing.
Crossref
Siri Bjornson, Carlina J. Grindeland & Amy B. Werremeyer. (2022) Impact of Implementing Screening and Interventions to Target Prevention of Opioid Misuse and Accidental Overdose in the Inpatient Setting. Journal of Pharmacy Practice, pages 089719002211441.
Crossref
Elizabeth Skoy, Oliver Frenzel, Heidi Eukel, Emily Lothspeich, Jayme Steig, Mark Strand & Amy Werremeyer. (2022) Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental Overdose. Preventing Chronic Disease 19.
Crossref
Emily Lothspeich, Amy Werremeyer, Sarah Chase & Andrea Huseth-Zosel. (2022) Patient Experience and Satisfaction with Opioid-Related Screening and Intervention in North Dakota Community Pharmacies. Journal of Pharmacy Practice, pages 089719002211095.
Crossref
Oliver Frenzel, Heidi Eukel, Emily Lothspeich, Elizabeth Skoy, Jayme Steig, Mark Strand & Amy Werremeyer. (2022) Opioid risk screening: Program evaluation from the community pharmacists’ perspective. Journal of the American Pharmacists Association 62:3, pages 859-863.e1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.